Encapsulating Synthetic STING Agonist, MSA-2, in Endosomolytic Polymersomes for Cancer Immunotherapy
Utilization of STING agonist MSA-2 encapsulated nanocarriers to enhance the immune system’s ability to eliminate cancer cells.
Posted by buchanle on Wednesday, June 25th, 2025 in May 2025, cancer, Flash nanoprecipitation, Immunotherapy, MSA-2, Nanocarrier, STING
In Vitro Analysis of Synergy between Adjuvants MPLA, CpG, and cGAMP for Treatment of Cancer
Synergistic application of adjuvants was used to analyze interferon and NF-κB immunological responses in mouse macrophages for the treatment of cancer.
Posted by John Lee on Tuesday, December 22nd, 2020 in May 2019, Adjuvant, Cancer Immunotherapy, Immunological response, STING pathway